Hyperstar Tablet 40/5mg

Adult dose

The recommended dose is 1 tablet once daily, to be taken with water regardless of meals. It is advised to take it at the same time every day (e.g., morning). - 40/5 mg: Administer to patients whose blood pressure is inadequately controlled with 5 mg amlodipine or 40 mg telmisartan. - 80/5 mg: Administer to patients whose blood pressure is inadequately controlled with 5 mg amlodipine or this medication 40/5 mg.

Child dose

Safety and efficacy in pediatric patients under 18 years of age have not been established, therefore use of this medication is not recommended.

This medication can cause severe side effects and risks of fetal death when used in pregnancy, especially during the second and third trimesters. Therefore, it must be discontinued immediately if pregnancy is confirmed. This medication should not be used in patients who are allergic to the active ingredients or similar components, pregnant or breastfeeding women, patients with severely impaired liver or heart function, and those with hypotension. Patients with mild liver function impairment or biliary obstruction, certain heart valve diseases, and severely impaired kidney function should use this medication with special caution. Common side effects include dizziness and peripheral edema, and there are rare reports of severe side effects, so if any unusual symptoms occur, medical consultation should be sought immediately. It is recommended not to use this medication during pregnancy and to consult with a doctor to choose another safe treatment if pregnancy is planned or ongoing. Patients with low fluid or sodium levels may experience excessively low blood pressure; prior to taking this medication, they should be fully replenished and should seek prompt assistance if symptoms of hypotension appear. Due to the risk of increased serum potassium levels, patients at risk of hyperkalemia should regularly check potassium levels through blood tests. Patients with impaired kidney function may experience changes in kidney function while taking this medication, so regular monitoring of kidney function is necessary. Patients with heart disease or congestive heart failure should be carefully observed as symptoms may worsen while taking this medication. This medication contains sorbitol, so patients with fructose intolerance should avoid it. Diabetic patients may have an increased risk of cardiovascular disease when taking this medication; hence, regular heart examinations are necessary, and coronary artery disease should be assessed even in the absence of symptoms. While taking this medication, drowsiness or dizziness may occur, so caution is advised when driving or operating dangerous machinery. This medication may interact with other antihypertensive drugs, so patients taking other medications should consult their doctor or pharmacist. In case of overdose, symptoms such as hypotension, arrhythmia, and dizziness may occur, which require immediate medical treatment, and this medication cannot be removed through hemodialysis. This medication should be stored out of the reach of children and protected from moisture and direct sunlight, ideally kept in its original packaging.

Serious side effects

• Urticaria
• angioedema (possibly fatal)
• Stevens-Johnson syndrome
• toxic epidermal necrolysis
• angioedema
• severe edema
• hepatitis
• jaundice
• thrombocytopenia
• leukopenia

Mild side effects

• Dizziness
• peripheral edema
• upper respiratory tract infection
• urinary tract infection
• cystitis
• anemia
• hyperkalemia
• hypoglycemia
• hyponatremia
• hyperglycemia

This medication should be stored in a light-resistant, closed container and kept at room temperature between 1 and 30 degrees Celsius. Proper storage helps maintain the effectiveness of the medication for a longer period.

Appearance

White and light blue, double convex oval biconvex tablet

Package unit

30 tablets/box [10 tablets/PTP*3], 30 tablets/bottle, 100 tablets/bottle